{"disease":{"id":"cytokine","name":"cytokine"},"drugs":{"marketed":[{"drug_id":"tocilizumab-or-sarilumab","indication_name":"Cytokine Release Syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"tocilizumab or sarilumab","generic_name":"tocilizumab-or-sarilumab","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"interleukin-6 receptor","drug_class":"monoclonal antibody","quality_score":10,"revenue":"116","mechanism":""},{"drug_id":"tocilizumab-or-sarilumab","indication_name":"Cytokine Release Syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"tocilizumab or sarilumab","generic_name":"tocilizumab-or-sarilumab","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"interleukin-6 receptor","drug_class":"monoclonal antibody","quality_score":10,"revenue":"116","mechanism":""},{"drug_id":"tocilizumab-or-sarilumab","indication_name":"Cytokine Release Syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"tocilizumab or sarilumab","generic_name":"tocilizumab-or-sarilumab","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"interleukin-6 receptor","drug_class":"monoclonal antibody","quality_score":10,"revenue":"116","mechanism":""},{"drug_id":"tocilizumab-or-sarilumab","indication_name":"Cytokine Release Syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"tocilizumab or sarilumab","generic_name":"tocilizumab-or-sarilumab","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"interleukin-6 receptor","drug_class":"monoclonal antibody","quality_score":10,"revenue":"116","mechanism":""},{"drug_id":"tocilizumab-or-sarilumab","indication_name":"Cytokine Release Syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"tocilizumab or sarilumab","generic_name":"tocilizumab-or-sarilumab","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"interleukin-6 receptor","drug_class":"monoclonal antibody","quality_score":10,"revenue":"116","mechanism":""},{"drug_id":"tocilizumab-or-sarilumab","indication_name":"Cytokine Release Syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"tocilizumab or sarilumab","generic_name":"tocilizumab-or-sarilumab","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"interleukin-6 receptor","drug_class":"monoclonal antibody","quality_score":10,"revenue":"116","mechanism":""},{"drug_id":"tocilizumab-or-sarilumab","indication_name":"Cytokine Release Syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"tocilizumab or sarilumab","generic_name":"tocilizumab-or-sarilumab","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"interleukin-6 receptor","drug_class":"monoclonal antibody","quality_score":10,"revenue":"116","mechanism":""},{"drug_id":"tocilizumab-or-sarilumab","indication_name":"Cytokine Release Syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"tocilizumab or sarilumab","generic_name":"tocilizumab-or-sarilumab","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"interleukin-6 receptor","drug_class":"monoclonal antibody","quality_score":10,"revenue":"116","mechanism":""},{"drug_id":"tocilizumab-or-sarilumab","indication_name":"Cytokine Release Syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"tocilizumab or sarilumab","generic_name":"tocilizumab-or-sarilumab","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"interleukin-6 receptor","drug_class":"monoclonal antibody","quality_score":10,"revenue":"116","mechanism":""},{"drug_id":"tocilizumab-or-sarilumab","indication_name":"Cytokine Release Syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"tocilizumab or sarilumab","generic_name":"tocilizumab-or-sarilumab","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"interleukin-6 receptor","drug_class":"monoclonal antibody","quality_score":10,"revenue":"116","mechanism":""},{"drug_id":"tocilizumab-or-sarilumab","indication_name":"Cytokine Release Syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"tocilizumab or sarilumab","generic_name":"tocilizumab-or-sarilumab","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"interleukin-6 receptor","drug_class":"monoclonal antibody","quality_score":10,"revenue":"116","mechanism":""},{"drug_id":"tocilizumab-or-sarilumab","indication_name":"Cytokine Release Syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"tocilizumab or sarilumab","generic_name":"tocilizumab-or-sarilumab","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"interleukin-6 receptor","drug_class":"monoclonal antibody","quality_score":10,"revenue":"116","mechanism":""},{"drug_id":"tocilizumab-or-sarilumab","indication_name":"Cytokine Release Syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"tocilizumab or sarilumab","generic_name":"tocilizumab-or-sarilumab","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"interleukin-6 receptor","drug_class":"monoclonal antibody","quality_score":10,"revenue":"116","mechanism":""},{"drug_id":"tocilizumab-or-sarilumab","indication_name":"Cytokine Release Syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"tocilizumab or sarilumab","generic_name":"tocilizumab-or-sarilumab","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"interleukin-6 receptor","drug_class":"monoclonal antibody","quality_score":10,"revenue":"116","mechanism":""},{"drug_id":"tocilizumab-or-sarilumab","indication_name":"Cytokine Release Syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"tocilizumab or sarilumab","generic_name":"tocilizumab-or-sarilumab","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"interleukin-6 receptor","drug_class":"monoclonal antibody","quality_score":10,"revenue":"116","mechanism":""},{"drug_id":"tocilizumab-or-sarilumab","indication_name":"Cytokine Release Syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"tocilizumab or sarilumab","generic_name":"tocilizumab-or-sarilumab","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"interleukin-6 receptor","drug_class":"monoclonal antibody","quality_score":10,"revenue":"116","mechanism":""},{"drug_id":"tocilizumab-or-sarilumab","indication_name":"Cytokine Release Syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"tocilizumab or sarilumab","generic_name":"tocilizumab-or-sarilumab","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"interleukin-6 receptor","drug_class":"monoclonal antibody","quality_score":10,"revenue":"116","mechanism":""},{"drug_id":"tocilizumab-or-sarilumab","indication_name":"Cytokine Release Syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"tocilizumab or sarilumab","generic_name":"tocilizumab-or-sarilumab","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"interleukin-6 receptor","drug_class":"monoclonal antibody","quality_score":10,"revenue":"116","mechanism":""},{"drug_id":"tocilizumab-or-sarilumab","indication_name":"Cytokine Release Syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"tocilizumab or sarilumab","generic_name":"tocilizumab-or-sarilumab","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"interleukin-6 receptor","drug_class":"monoclonal antibody","quality_score":10,"revenue":"116","mechanism":""},{"drug_id":"tocilizumab-or-sarilumab","indication_name":"Cytokine Release Syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"tocilizumab or sarilumab","generic_name":"tocilizumab-or-sarilumab","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"interleukin-6 receptor","drug_class":"monoclonal antibody","quality_score":10,"revenue":"116","mechanism":""},{"drug_id":"tocilizumab","indication_name":"Cytokine release syndrome induced by tumor-specific T-cell infusion therapy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Roactemra","generic_name":"tocilizumab","company_name":"Roche","drug_phase":"marketed","molecular_target":"Interleukin-6 receptor","drug_class":"Interleukin-6 Receptor Antagonist [EPC]","quality_score":10,"revenue":null,"mechanism":"Roactemra works by blocking the interleukin-6 receptor, a protein that plays a key role in inflammation."}],"pipeline":[],"offLabel":[],"totalMarketed":21,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06622304","title":"Exploring the Effects of Antihypertensive and Lipid-Lowering Drugs on Inflammatory Cytokine Levels","phase":"","overall_status":"COMPLETED","enrollment_count":250736,"lead_sponsor_name":"Guangzhou Institute of Respiratory Disease","has_results":false},{"nct_id":"NCT04413747","title":"Yoga Pranayama Adjuvant to Treat Burden COVID-19","phase":"NA","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Health Ricerca e Sviluppo S.R.L.","has_results":false},{"nct_id":"NCT04486521","title":"Anti-IL6 and Corticosteroid Monotherapy vs Combination in COVID-19","phase":"","overall_status":"UNKNOWN","enrollment_count":860,"lead_sponsor_name":"King Faisal Specialist Hospital & Research Center","has_results":false},{"nct_id":"NCT07070180","title":"Analysis of Psychoneuroimmunological Parameters of Health in Specific Population Groups in Slovakia","phase":"","overall_status":"COMPLETED","enrollment_count":700,"lead_sponsor_name":"Comenius University","has_results":false},{"nct_id":"NCT04492501","title":"Investigational Treatments for COVID-19 in Tertiary Care Hospital of Pakistan","phase":"NA","overall_status":"COMPLETED","enrollment_count":600,"lead_sponsor_name":"UNICEF","has_results":false},{"nct_id":"NCT04366908","title":"Prevention and Treatment With Calcifediol of COVID-19 Induced Acute Respiratory Syndrome","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":517,"lead_sponsor_name":"Maimónides Biomedical Research Institute of Córdoba","has_results":false},{"nct_id":"NCT04362813","title":"Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":454,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT04362137","title":"Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":432,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT06735365","title":"Comparative Effectiveness of Oxiris Hemofilters Versus Conventional Hemofilters in Septic Patients","phase":"","overall_status":"COMPLETED","enrollment_count":426,"lead_sponsor_name":"Bakirkoy Dr. Sadi Konuk Research and Training Hospital","has_results":false},{"nct_id":"NCT05096052","title":"PROlectin M, a Nucleocapsid TErminal GaleCTin Antagonist for COVID-19","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":408,"lead_sponsor_name":"Bioxytran Inc.","has_results":false},{"nct_id":"NCT05491304","title":"Cytokine Guided Risk Stratification and Treatment in Pediatric Hemophagocytic Lymphohistiocytosis","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"The Children's Hospital of Zhejiang University School of Medicine","has_results":false},{"nct_id":"NCT05476848","title":"Relationship Between Oral Findings and Salivary Factors in Sars-Cov-2 Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":320,"lead_sponsor_name":"Ege University","has_results":false},{"nct_id":"NCT06491966","title":"Clinical Outcomes and Inflammatory Responses in Viral vs. Bacterial Sepsis","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Sichuan Provincial People's Hospital","has_results":false},{"nct_id":"NCT05013034","title":"Exploratory Regimen of Basiliximab for Treatment of Pulmonary Cytokine Storm in SARS-CoV-2 Hospitalized Adult Patients","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Fort Worth Clinical Sciences Working Group","has_results":false},{"nct_id":"NCT04485169","title":"Therapeutic Plasma Exchange for Coronavirus Disease-2019 Triggered Cytokine Release Storm;","phase":"NA","overall_status":"COMPLETED","enrollment_count":280,"lead_sponsor_name":"UNICEF","has_results":false},{"nct_id":"NCT07501455","title":"Comparison of the Effects of Oral Hygiene Regimens on Clinical, Immunomodulatory, and Microbial Outcomes and Oral Tolerance in People With Gingivitis","phase":"NA","overall_status":"RECRUITING","enrollment_count":250,"lead_sponsor_name":"Kenvue Brands LLC","has_results":false},{"nct_id":"NCT04309591","title":"Cytosorb Therapy in Cardiac Surgery","phase":"","overall_status":"COMPLETED","enrollment_count":249,"lead_sponsor_name":"University Hospital, Basel, Switzerland","has_results":false},{"nct_id":"NCT03557749","title":"Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies","phase":"","overall_status":"TERMINATED","enrollment_count":210,"lead_sponsor_name":"Masonic Cancer Center, University of Minnesota","has_results":false},{"nct_id":"NCT06243497","title":"Comparison of Cytokines Profile in Aqueous Humor and Tear Before and After UCP Treatment","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Zhongshan Ophthalmic Center, Sun Yat-sen University","has_results":false},{"nct_id":"NCT05136183","title":"CLinical Efficacy of Hemoperfusion With a Cytokine Adsorber in Norepinephrine-Resistant SEptic Shock","phase":"NA","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Mahidol University","has_results":false},{"nct_id":"NCT05611710","title":"Anakinra in Dengue With Hyperinflammation ( AnaDen )","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":160,"lead_sponsor_name":"Oxford University Clinical Research Unit, Vietnam","has_results":false},{"nct_id":"NCT04734678","title":"Comparison of Tocilizumab Versus Tocilizumab/Infliximab in Patients With COVID-19-associated Cytokine Storm Syndrome","phase":"","overall_status":"COMPLETED","enrollment_count":153,"lead_sponsor_name":"Ain Shams University","has_results":false},{"nct_id":"NCT06390748","title":"Esmolol in Sepsis Management:Evaluating Immunomodulatory Effects and Impact on Patient Outcomes","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Lin Chen","has_results":false},{"nct_id":"NCT07164014","title":"The Impact of the Mediterranean Diet on Anthropometric Indices, Lipid Profiles, Energy Metabolism Signaling Proteins and Inflammatory Cytokines in Psychiatric Patients With Metabolic Syndrome","phase":"NA","overall_status":"COMPLETED","enrollment_count":144,"lead_sponsor_name":"King Saud University","has_results":false},{"nct_id":"NCT01419561","title":"Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":140,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT07499128","title":"Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":136,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT04403685","title":"Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory Markers","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":129,"lead_sponsor_name":"Beneficência Portuguesa de São Paulo","has_results":false},{"nct_id":"NCT06404203","title":"The Effect of Oral Use of Lyophilised Royal Jelly on Cognitive Functions and Immune System in Elderly Individuals","phase":"NA","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Medipol University","has_results":false},{"nct_id":"NCT04306705","title":"Tocilizumab vs CRRT in Management of Cytokine Release Syndrome (CRS) in COVID-19","phase":"","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT05315388","title":"Effects of \"Vitamin N\" Nature Immersion Therapy on Stress Levels in Health Care Workers in the City of Bogotá","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":118,"lead_sponsor_name":"Jeadran N. Malagón-Rojas","has_results":false},{"nct_id":"NCT04738760","title":"Clinical Outcomes of High Dose Vitamin D Versus Standard Dose in COVID-19 Egyptian Patients","phase":"","overall_status":"COMPLETED","enrollment_count":116,"lead_sponsor_name":"Ain Shams University","has_results":false},{"nct_id":"NCT04071366","title":"A Study of Itacitinib for the Prevention of Cytokine Release Syndrome Induced by Immune Effector Cell Therapy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":112,"lead_sponsor_name":"Incyte Corporation","has_results":true},{"nct_id":"NCT06684015","title":"The Effect of Intrathecal Morphine and Erector Spina Plan Block on Serum Cytokine Levels and Chronic Pain in Caesarean Section Surgery","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":110,"lead_sponsor_name":"Ankara University","has_results":false},{"nct_id":"NCT04403061","title":"Th1/Th2/Th17/TREG and TLRs Activation/KIR for COVID 19 Prediction of Outcome","phase":"","overall_status":"COMPLETED","enrollment_count":106,"lead_sponsor_name":"Asociacion para el Estudio de las Enfermedades Infecciosas","has_results":false},{"nct_id":"NCT04667507","title":"Pharmacokinetics of Aqueous Dexamethasone","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":102,"lead_sponsor_name":"Frank A. Bucci, Jr., M.D.","has_results":false},{"nct_id":"NCT00089739","title":"Immune Indicators of Uveitis","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"National Eye Institute (NEI)","has_results":false},{"nct_id":"NCT05408325","title":"Intercellular Adhesion Molecule-1 and TNF-α in Patients With COVID-19","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Benha University","has_results":false},{"nct_id":"NCT04483271","title":"The Effect of Omega-3 on Selected Cytokines Involved in Cytokine Storm","phase":"NA","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Applied Science Private University","has_results":false},{"nct_id":"NCT03623763","title":"Vitamin D Level Among Athletes in Uzbekistan","phase":"","overall_status":"SUSPENDED","enrollment_count":100,"lead_sponsor_name":"Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan","has_results":false},{"nct_id":"NCT06377059","title":"Early Detection of Complications During Immunotherapy for Haematological Malignancy","phase":"NA","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT04476745","title":"The Effect of D3 on Selected Cytokines Involved in Cytokine Storm in the Covid-19 Uninfected Jordanian People","phase":"NA","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Applied Science Private University","has_results":false},{"nct_id":"NCT06150066","title":"The Effect of Smoking on Peri-implantitis","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":96,"lead_sponsor_name":"Mustafa Kemal University","has_results":false},{"nct_id":"NCT04293380","title":"Amniotic Fluid Ischemia Modified Albumin as a Novel e Prenatal Diagnostic Marker for Down Syndrome","phase":"NA","overall_status":"COMPLETED","enrollment_count":94,"lead_sponsor_name":"Karadeniz Technical University","has_results":false},{"nct_id":"NCT04517162","title":"Intramuscular Effect of Polymerized Type I Collagen on the Cytokine Storm in COVID-19 Patients","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":90,"lead_sponsor_name":"Janette Furuzawa Carballeda","has_results":false},{"nct_id":"NCT07485517","title":"Deep Versus Moderate Neuromuscular Blocking","phase":"NA","overall_status":"RECRUITING","enrollment_count":88,"lead_sponsor_name":"Menoufia University","has_results":false},{"nct_id":"NCT06250075","title":"Effects of the Use of Probiotics on the Intestinal Microbiota of Patients With Gastric Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":88,"lead_sponsor_name":"Universidade Federal do Amazonas","has_results":false},{"nct_id":"NCT03264846","title":"Endocan Levels at Polycystic Ovary Syndrome and Periodontal Inflammation","phase":"","overall_status":"COMPLETED","enrollment_count":87,"lead_sponsor_name":"Ebru Saglam","has_results":false},{"nct_id":"NCT04567199","title":"Influence of Cytosorb on Amount of Catecholamine and Mortality in Sepsis","phase":"","overall_status":"COMPLETED","enrollment_count":86,"lead_sponsor_name":"Medical University Innsbruck","has_results":false},{"nct_id":"NCT06970964","title":"Fermented Milk Drink With Lacticaseibacillus Paracasei Strain Shirota Helps Triathletes With Cold-Like Symptoms Before and After a Race","phase":"NA","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Federal University of São Paulo","has_results":false},{"nct_id":"NCT05436938","title":"To Evaluate the Mechanism of Jing Si Herbal Tea Liquid Packets and Traditional Western Medicine for Psoriasis","phase":"NA","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Buddhist Tzu Chi General Hospital","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}